Dissertation > Excellent graduate degree dissertation topics show

Yiqihuoxue Compound on chronic heart failure myocardial type Ⅰ, Ⅲ collagen expression in rats

Author: ZhangYang
Tutor: ZhangYan
School: Liaoning University of Traditional Chinese Medicine
Course: Traditional Chinese Medicine
Keywords: Yi Qi Huo xue Compound prescription ColⅠ ColⅢ Chronic heart failure Ventricular remodeling
CLC: R285
Type: Master's thesis
Year: 2011
Downloads: 64
Quote: 0
Read: Download Dissertation

Abstract


Purpose:The experiment by establishing chronic heart falling (CHF) model rats, and observe chinese medicine the benefiting Qi and activating Blood compound to CHF rats expression of ColⅠ, ColⅢ. From protein learn, genes, and organizational forms to learn and study its function and role of the mechanism; for the chinese medicine prevent and treat CHF to open up new ideas and objective scientific experimental basis.Material and method:1. Male common grade 60 SD rats of weighing from 200~230g were used,and applicably feed on a week. CHF model rats model by ligating coronary artery with exhaustive style swimming , hunger and other methods, then detecte ejection fraction (EF) and so on by Doppler echocardiography, and the status of the rats, determine the success of the modeling.2. To successful CHF model rats divided into western medicine group,traditional chinese medicine group, model group, and set up the blank control group. Blank control group and model group did not medicate, only fed saline water of conventional volume, rats in medication groups taked medicine by ratand men dose formula , western medicine group dosed La nuo pu li; traditional chinese medicine group dosed Yi Qi Huo xue Compound prescription.6 weekslater , all groups rats were killed after anesthesia, left the heart myocardium.3. Using real time quantitative PCR, Western blot method,and HE staining and immunohischemistry observed under light microscope to compare the chinesemedicine group,western group and blank control group, model group with CHF cardiac ColⅠ, ColⅢand the changes in morphological changes among groups. Results:1. Chronic heart failure animal model group ColⅠ, ColⅢmRNA expression was significantly decreased ,compared with the control group P<0.01; except western group ColⅠmRNA slightil decreased,compared with the model group P>0.05;by drugs intervention ColⅠ, ColⅢmRNA of each treatment group was significantly increased, compared with model group P<0.01;compared with Chinese medicine group statistically significant,P<0.01.2. CHF model group, the expression of Col,ColⅢwas significantly decreased,compared with the control group P<0.01; by drugs intervention ColⅠ, ColⅢexpression of each treatment group was significantly higher, compared withthe modle group P<0.01; ColⅠchinese medicine group compared with western medicine group medicine group,P<0.01;ColⅢchinese medicine group compared with western medicine group medicine group,P>0.05.3. The myocardium cells of blank control group:regular arrangement, normal size ,stripes clear, and orderly arrangement of myofibrils. Model group:myocardium cells formed extensive networks, can not observe clear stripes and disordered myofibrils, the blank area heterochromatin present mass, adjacent cells in the intercalated disk space widened.Western medicine group :myocardium cells arranged in regular , most of the myocardium cells on the edgeof myocardium cells, shape, size normal and more orderly arrangement ofmyofibrils.Chinese medicine group: myocardium cells arranged in regular, can observe clear stripes, myocardium cells were shrunk to a more solid round,onthe edge of myocardium cells, a more orderly arrangement of myofibrils stillshowde that there were faults and defects and the blank area.4. The average gray of CHF model group ColⅠanalyzing by software was 45.34±8.10 ,using immunohistochemistry ,compared with the control group P<0.01;Chinese medicine group impression significantly was 468.86±9.87,compared with model group, P <0.01; Western group was 396.20±39.95 ,compared with model group, P<0.01,there is significant difference among western group and chinese medicine,P>0.05.5. The average gray of Chronic heart failure model group ColⅢanalyzing b y software was 61.46±7.11, using immunohistochemistry,compared with the blank control group P<0.01; Western group was the most obvious , 132.40±55.34 ,compared with the model group, P<0.01; Chinese medicine group was 108.26±8.89,compared with the model group, P<0.01;there is significant difference among western group and chinese medicine P>0.05.Conclusion:1. Through the rats use a combination of the coronary artery ligated, hungry, and exhausted swimming,methods, ultrasound echocardiography detected by the rats and left ventricular function of its actions, prove that the changes made by the method is feasible.2. After 6 weeks treatment, by using Western blot, real time quantitative PCR, HE method dyeing detect ColⅠand ColⅢcontent of CHF rats myocardial tissue , found that ColⅠand ColⅢContent of Yi qi huo xue compound prescription was significantly higher than the model group myocardium tissue,and precede western medicine group ;furthermore,it can improve myocardium structure;to clue:Yi qi huo xue compound prescription can regulate myocardium ColⅠand ColⅢcontent and improve myocardium structure , thus to prevent and treat function of CHF.

Related Dissertations

  1. Research on the Correlativity between the Common Chinese Medicine Syndromes of CHF and UA、LVMI,R259
  2. Medical interventions for patients with chronic heart failure heart rate variability,R259
  3. Effects of 17β-E2 and chOPG on Proliferation, Apotosis, Cell Cycle, and mRNA Expression of BGP and Col Ⅰ of Ostoblasts Induced from BMSCs in Chicken Embryos,S858.31
  4. Application Evaluation normal serum creatinine glomerular filtration rate in patients with chronic heart failure, renal function,R541.61
  5. Prognosis in patients with chronic heart failure multivariate analysis,R541.6
  6. Effect of H2 O2 Pretreatment of Autologous Mesenchymal Stem Cells Transplantation on Ventricular Remodeling After Acute Myocardial Infarction,R542.22
  7. Application of Heart Function Echocardiographic Multi-Parameter Score (HF- EMPS) in Assessment of Response to the Guideline-recommended Treatments of Chronic Heart Failure (CHF),R541.6
  8. The Significance of Microalbuminuria in the Assessment of the Severity and Prognosis of Chronic Heart Failure,R541.61
  9. Self-management Programme Improving Prognosis in Patients with Chronic Heart Failure,R541.61
  10. Red Blood Cell Distribution Width as a Prognostic Marker for Patients with Chronic Heart Failure,R541.6
  11. The Relationship between Expression of Interleukin-17 and Ventricular Arrhythmia in Rats with Chronic Heart Failure,R541.7
  12. The Change of Hepatic Oval Cells and Kinds of Related Cytokines in Biliary Obstruction Model,R575
  13. The Expression and Significance of NHE-1 in Myocardium and Plasma in Cardiac Hypertrophy Rats and Chronic Heart Failure Rats,R541.6
  14. Evaluation of Cardiac Resynchronization Therapy in Chronic Heart Failure by Echocardiography,R541.6
  15. Relationship of Depression to Ventricular Remoding in Patients with Chronic Ischemic Heart Failure,R541.6
  16. Study on Difference among the TCM Syndrome of Chronic Heart Failure in Terms of Cardiac Index and Left Ventricular Mass Index,R259
  17. Chronic Heart Failure TCM Syndrome Clinical Retrospective Investigation Research,R259
  18. Clinical Observation on Treatment of Chronic Heart Failure by TianXiangDan Combined,R259
  19. The Clinical Research about Comprehensive Intervention of Traditional Chinese Medicine on Chronic Heart Failure,R259
  20. Tongmai Granules treatment of cardiac qi deficiency and blood stasis with chronic heart failure in 60 patients,R259
  21. Soup of the strong Fumai the treatment of coronary heart disease with heart failure 31 cases,R259

CLC: > Medicine, health > Chinese Medicine > Of Pharmacy > Pharmacology
© 2012 www.DissertationTopic.Net  Mobile